A small molecule redistributes iron in ferroportin-deficient mice and patient-derived primary macrophages.
Ontology highlight
ABSTRACT: Deficiencies of the transmembrane iron-transporting protein ferroportin (FPN1) cause the iron misdistribution that underlies ferroportin disease, anemia of inflammation, and several other human diseases and conditions. A small molecule natural product, hinokitiol, was recently shown to serve as a surrogate transmembrane iron transporter that can restore hemoglobinization in zebrafish deficient in other iron transporting proteins and can increase gut iron absorption in FPN1-deficient flatiron mice. However, whether hinokitiol can restore normal iron physiology in FPN1-deficient animals or primary cells from patients and the mechanisms underlying such targeted activities remain unknown. Here, we show that hinokitiol redistributes iron from the liver to red blood cells in flatiron mice, there
SUBMITTER: Ekaputri S
PROVIDER: S-EPMC9245668 | biostudies-literature | 2022 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA